Gritstone bio, Inc. (OTC: GRTSQ), a clinical-stage biotechnology company working to develop the world's most potent vaccines, ...

Preclinical data has suggested that the combination therapy could potentially optimise outcomes for patients with recurrent ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, off-the-shelf c ...

Infinitopes' lead vaccine candidate ITOP1 is a novel, precision targeted, immunologically durable, "off-the-shelf" cancer vaccine, designed to save lives by preventing disease recurrence in first-line ...

In the first study, titled "The Anti-tumor Response of BPM31510 is Associated with Immune Cell Regulation in the Tumor Microenvironment," researchers showed that BPM31510 significantly increases ...

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses.

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable spillover of a family of organisms called arteriviruses. In a new study, ...

New study of ‘immune memory’ and T-cells has the goal of coming up with the next wave of immunotherapy, UCSD researcher says ...

Scientists investigating animal viruses with potential to infect humans have identified a critical protein that could enable ...

AbbVie’s deal team is having a busy week. Days after inking a $1.4 billion buyout, the drugmaker has put up the same again in biobucks to secure options on multispecific T-cell engagers from ...

Cedric Pioline, director of the Paris Masters, commented on Jannik Sinner's withdrawal and expressed his concerns about the Six Kings Slam and the involvement of top stars on the Tour. The Italian ...

Months before the University of Iowa in May named Jill Kolesar its next College of Pharmacy dean, she applied in January for ...